Evra Research Publishes Review on AI for Chronic Disease Prevention & Management

November 7, 2025

Today, we are excited to share that our first research paper,
“Artificial Intelligence and Integrative Approaches to Chronic Disease Management: A Scoping Review,”
has been posted to SSRN, a leading preprint server for public health, science, and social science.
The paper has concurrently been submitted for peer-review.

This work represents an important milestone for Evra Health and our mission to build a rigorous, science-aligned foundation for AI-powered preventive care — partnering with experts in academia to help support scientific research.

While AI has enormous potential to transform chronic disease prevention and management, not all innovations in this space are grounded equally in evidence, ethics, and measurable outcomes.
Our goal with this review is to cut through hype, surface what the science truly shows, and highlight the real-world considerations needed to ensure patient-centered, equitable, and effective deployment of these tools.

Why We Conducted This Review

Chronic diseases such as diabetes, cardiovascular disease, hypertension, and obesity account for the majority of morbidity, mortality, and healthcare spending worldwide.

At the same time, we are witnessing unprecedented advances in AI — from predictive models and digital twins to large language models capable of continuous health coaching and shared decision-making support.

Yet despite the promise, the field remains fragmented. Findings are emerging across industry pilots, academic centers, and digital health programs, but until now, there has been no cohesive map of the landscape that brings together clinical, behavioral, and integrative medicine perspectives.

We undertook this work to answer a simple but urgent question:

Where can AI genuinely advance preventive and integrative care today — and where are we not ready yet?

What We Found

Our review identifies four major domains where AI is influencing chronic disease care:

1. Prediction & Early Detection

AI models, including transformer-based systems and multimodal architectures, are improving risk prediction and early detection for conditions like type 2 diabetes and cardiovascular disease.
Digital twin systems and real-time physiological analysis show particular promise.

2. Personalized Prevention & Coaching

Large Language Models (LLMs) and adaptive feedback systems are emerging as supportive tools for health behavior change, from meal planning to activity guidance to stress management and sleep patterns.

3. Continuous Monitoring & Precision Support

Wearables, EHR signals, and biometric data streams allow for continuous, contextualized care — unlocking the potential for more timely intervention and long-term adherence support.

4. Integrating Lifestyle & Clinical Care

AI tools are beginning to bridge clinic and lifestyle domains, creating opportunities to bring evidence-based integrative medicine principles — including nutrition, movement, recovery, and psychosocial support — into scalable care delivery.

Where Caution Is Essential

The review also highlights several critical challenges:

Algorithmic bias & data inequity
Regulatory uncertainty and lack of clarity on clinical standards
Privacy, security, and data provenance concerns
Variable quality of evidence and heterogeneous study designs
Risks of over-automation and erosion of human connection in care

While AI is already delivering meaningful benefits, we emphasize that responsible deployment requires guardrails, humility, and rigorous validation.

The goal isn’t to replace clinicians, coaches, or community care —
but to enhance human capacity, compassion, and precision, especially in prevention and long-term support.

Why This Matters for Evra

At Evra, we’re building a preventive health intelligence platform grounded in scientific rigor, clinical wisdom, and respect for the human experience of behavior change and healing.

We believe deeply that AI for health must be built differently — with transparency, safety, and real outcome measurement at the core.

This research effort underscores our commitment to:

Evidence-based innovation
Independent scientific inquiry
Responsible AI development
Equity, ethics, and human-first care
Long-term health outcomes over short-term hype

Our work does not end with publication — it begins here.
We will continue to publish research, validate our methods, and collaborate with academic institutions and the clinical community as we move toward our product rollout.

Looking Ahead

We hope this scoping review provides value to:

Academic researchers exploring AI-enabled preventive care
Clinicians and health leaders evaluating new technology
Industry partners and investors building toward trust and scientific rigor
Policymakers and ethics leaders shaping the future of AI governance
Patients and families seeking credible, compassionate innovation

We warmly invite collaboration, critique, and dialogue as we move forward.

The full preprint is available on SSRN here:
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5708362

DOI: 10.2139/ssrn.5708362

About Evra Health

Evra Health is building a next-generation preventive health platform powered by intelligent, ethical AI — designed to help individuals reduce risk, reverse disease when possible, and build health with agency and clarity.
We fuse clinical science, lifestyle medicine, and human-centered design to help people live longer, healthier lives.